🇺🇸 Preservative Free Morphine in United States
18 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 18
Most-reported reactions
- Atrioventricular Block Second Degree — 3 reports (16.67%)
- Drug Ineffective — 3 reports (16.67%)
- Headache — 2 reports (11.11%)
- Hypertonia — 2 reports (11.11%)
- Nodal Rhythm — 2 reports (11.11%)
- Sinus Bradycardia — 2 reports (11.11%)
- Arachnoiditis — 1 report (5.56%)
- Atrioventricular Block First Degree — 1 report (5.56%)
- Convulsion — 1 report (5.56%)
- Drug Effect Decreased — 1 report (5.56%)
Other Pain Management approved in United States
Frequently asked questions
Is Preservative Free Morphine approved in United States?
Preservative Free Morphine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Preservative Free Morphine in United States?
Icahn School of Medicine at Mount Sinai is the originator. The local marketing authorisation holder may differ — check the official source linked above.